NSE - Delayed Quote INR

Gufic Biosciences Limited (GUFICBIO.NS)

Compare
343.80
+3.35
+(0.98%)
At close: 3:29:53 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Jayesh Pannalal Choksi Chairman & MD 4.82M -- 1954
Mr. Pranav Jayesh Choksi CEO & Whole Time Director 4.43M -- 1983
Mr. Pankaj Jayakumar Gandhi Whole-Time Director 1.74M -- 1959
Mr. Devkinandan B. Roonghta Chief Financial Officer 2.96M -- 1965
Mr. Nagesh Yarrabathina Chief Operating Officer -- -- --
Ms. Ami Naresh Shah Company Secretary, Compliance Officer & Legal Manager 892.96k -- --
Mr. Pinak Padhya Associate Vice President - Sales & Marketing -- -- --
Mr. Sunil Desai Head – Human Resource Department -- -- --
Mr. Ashok Laxman Dev President of Operation -- -- --
Mr. Shekhar Tarabir Aley Senior Vice President - Critical Care SBUs, Nepal & Institution -- -- --

Gufic Biosciences Limited

S.M. House
1st to 4th Floor 11, Sahakar Road Vile Parle (East)
Mumbai, 400057
India
91 22 6726 1000 https://www.gufic.com
Sector: 
Healthcare
Full Time Employees: 
1,491

Description

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.

Corporate Governance

Gufic Biosciences Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 27, 2025 at 10:59 AM UTC - May 31, 2025 at 12:00 PM UTC

Gufic Biosciences Limited Earnings Date

Recent Events

September 18, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

GUJTHEM.NS Gujarat Themis Biosyn Limited
290.15
+4.18%
 
INDOCO.NS Indoco Remedies Limited
239.78
+2.70%
 
WINDLAS.BO Windlas Biotech Limited
1,066.90
-0.34%
 
INNOVACAP.NS Innova Captab Limited
903.65
+0.68%
 
WINDLAS.NS Windlas Biotech Limited
1,067.50
-0.21%
 
AMRUTANJAN.NS Amrutanjan Health Care Limited
685.40
+2.37%
 
NEULANDLAB.NS Neuland Laboratories Limited
12,749.00
+0.70%
 
ABBOTINDIA.NS Abbott India Limited
30,710.00
-0.78%
 
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,356.80
-1.46%
 
WOCKPHARMA.NS Wockhardt Limited
1,392.40
-0.71%